Speakers

Joel Eichmann

Co-Founder & Managing Director • Green Elephant Biotech

Joel Eichmann is a life scientist with a background in bioprocess engineering, manufacturing, and synthetic biology. Before founding Green Elephant Biotech, he worked several years in the pharmaceutical industry in vaccine manufacturing and tech transfer projects. Now at Green Elephant Biotech he is leading the development of new products and acts as a linker between business development and R&D. He is also passionate about building a greener future for the pharmaceutical industry and helping manufacturers and researchers to reduce their environmental impact.

Also speaking

Tanya Sharma

Co-Founder • Assurea LLC

Paolo Morgese

Head of Public Affairs, Europe • Alliance for Regenerative Medicine

Michal Besser

Chief Technology Officer, Davidoff Cancer Center • Rabin Medical Center

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.

Speakers

Diego Bochicchio

Director of Quality, Compliance & Regulatory EU • CAI – Commissioning Agents Inc

Diego is a Quality Operations and Business Principal Consultant with 27+ years of experience primarily in the Pharmaceuticals and Medical Devices Industries. He received first-class honors degree cum laude in Pharmaceutical Chemistry (CTF) and degree as a Pharmacist. Diego is a Qualified Person (QP) and a Senior International Auditor. He has a senior expertise in QA, GMP Compliance, FDA-readiness, Quality Systems and Operations, Warehousing and Distribution Practices (GDPs), Business Development. Diego is highly pragmatic, hands-on, change-oriented, and open to different company cultures

Also speaking

Kate Fynes

CMC Translation Consultant • eXmoor Pharma

Ben Weil

Director of Manufacturing  • INmune Bio

Tomer Bronshtein

Vice President, Business Development • Bonus Biogroup

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.

Speakers

Sofia Venceslau

Senior Project Manager • ReciBioPharm

Dr. Sofia Venceslau is passioned about biochemistry and microbial organisms, with strong experience in USP and DSP of microbial systems and with over 20 publications in the field. Sofia joined GenIbet Biopharmeuticals, now ReciBioPharm, in 2019 where she is involved in an end-to-end solution to clients starting on business development, monitoring process development activities, responsible for the process technology transfer, scaling up and implementation of good manufacturing practices, assisting the success of the client´s project from the bench to clinical trials (phase 1 to 3). The portfolio includes manufacturing processes of different areas (protein vaccines, virus oncolytic vaccines, mRNA, DNA, live microbial products, etc) using different systems (bacteria, yeast, mammalian and insect cells, or in vitro systems).

Also speaking

Tobias Brandt

Senior Scientist, Viral Vector Process Development • CSL Behring

Mantej Chhina

Executive Director, Head of Global R&D Regulatory Policy • BioMarin

Stefanie Urlinger

Chief Scientific Officer • Cimeio Therapeutics

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.

Speakers

Dale Stibbs

Post-Doctoral Fellow • UCL

Dale is a postdoctoral research fellow working in Professor Qasim Rafiq’s Cell and Gene Therapy Bioprocessing Group at University College London (UCL). His current project is focused on establishing scalable adeno-associated viral vector manufacturing processes, which is undertaken as part of the UCL-Cytiva Centre of Excellence. Previously, Dale completed his engineering doctorate (EngD) focused on establishing a continuous lentiviral vector manufacturing process in collaboration with Cytiva at UCL  

Also speaking

Marc Davies

Vice President of R&D • Leucid Bio

Simon Jones

Professor of Pediatrics and Translational Medicine • University of Manchester

Lucy Ellerker-Jones

Founder • Opie Jones Foundation

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.

Speakers

Robert Allen

Managing Partner, General Manager • Dark Horse Consulting Group

Rob is one of three Managing Partners who run the Dark Horse Consulting Group practice (the other two being DHC’s Founder and CEO, Anthony Davies and DHC’s COO, Katey Spink). Rob joined DHC in early 2019 as a Principal on what was then a much smaller consulting team. His expertise ranged from manufacturing to process development to regulatory, as well as project/program management, market research, and due diligence/business strategy. During his tenure, the UK-based team grew rapidly (from two individuals to thirteen as of 2022) and in 2021, Rob became General Manager of the UK office and European team, aka DHC Europe, Ltd.

Also speaking

Matthew Lakelin

Vice President, Scientific Affairs & Product Development, Co-Founder • Trakcel

Niloofar Davoodi

Product Operations Lead, Cell Therapy • Takeda

Pedro Silva Couto

Post Doctoral Research Fellow • UCL

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.

Speakers

Elisabet Aguilar

Speakers

Ruud Das

Speakers

Pedro Silva Couto

Speakers

Jack Reid

Speakers

Bernd Eschgfaeller

Independent Board Member • T-CURX

Bernd is very passionate about providing new and improved treatment options to patients in need. 

He has profound experience in the field of CAR-T therapy development and the commercialization of CAR-T cells. He most recently served as Head Customer Operations for cell & gene therapies at Novartis and was a member of the European cell & gene leadership team launching and commercializing Kymriah®, the first FDA-approved CAR-T cell product. Prior to that, Bernd was leading the cell therapies strategy development for Europe shaping the design of the commercial model for CAR-T provision. 

He helped to bring to market multiple new therapies during his extensive 20-years experience working in Lifesciences in pharma and biotech. He holds a Ph.D. in natural sciences from the ETH Zurich, Switzerland. 

Also speaking

Dorothea Ledergerber

Chief Technical Officer • Tigen Pharma

Jessica Berlier

Director P&AD • Catalent Cell & Gene Therapy

Elisabetta Zanon

Director of EU Public Affairs & Advocacy • Alliance for Regenerative Medicine

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.